Neuropsychiatric Symptom Assessments in Toxic Exposure

Psychiatric Clinics of North America

Volumn 36, Issue 2, 2013, Pages 201-208

  Mason, Lisa H ^a   Mathews, Melissa J ^a   Han, Dong Y ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Neuropsychiatric assessment; Neurotoxin; Toxic exposure; Toxin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ACETYLCHOLINE; ANTIRETROVIRUS AGENT; CANNABIS; CHOLINESTERASE; HEAVY METAL; INDUSTRIAL TOXIC SUBSTANCE; LEAD; LIDOCAINE; LITHIUM; MANGANESE; OPIATE; ORGANIC SOLVENT; ORGANOPHOSPHATE;

ACETYLCHOLINE RELEASE; ACUTE TOXICITY; AGITATION; ANXIETY; ATAXIA; AUDITORY HALLUCINATION; BECK ANXIETY INVENTORY; BECK DEPRESSION INVENTORY; BEHAVIOR DISORDER; BRIEF SYMPTOM INVENTORY; CAPGRAS SYNDROME; CENTRAL NERVOUS SYSTEM DISEASE; CHOLINESTERASE INHIBITION; CLINICAL EVALUATION; CLINICAL FEATURE; COGNITIVE DEFECT; COMA; COMPULSION; CONFUSION; DELUSION; DEPRESSION; DIARRHEA; DIZZINESS; DSM-IV; DYSPHORIA; EUPHORIA; EXCITABILITY; EXECUTIVE FUNCTION; FATIGUE; GASTROINTESTINAL SYMPTOM; HALLUCINATION; HEADACHE; HOLISTIC CARE; HOSTILITY; HUMAN; HYPOMANIA; IMPULSIVENESS; IRRITABILITY; KIDNEY INJURY; LONG TERM EXPOSURE; MENTAL DISEASE; MENTAL INSTABILITY; MINNESOTA MULTIPHASIC PERSONALITY INVENTORY; MOOD CHANGE; MOOD DISORDER; MOTOR DYSFUNCTION; NAUSEA; NERVE DEGENERATION; NEUROLOGIC DISEASE; NEUROTOXICITY; OCCUPATIONAL TOXICOLOGY; PARANOIA; PARKINSON DISEASE; PHOBIA; PRIORITY JOURNAL; PROFILE OF MOOD STATES; PSYCHOLOGIC ASSESSMENT; PSYCHOSIS; REVIEW; SEIZURE; SELF EVALUATION; SELF REPORT; SIDE EFFECT; SLEEP DISORDER; SOMATIZATION; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; SYMPTOM CHECKLIST 90; SYMPTOMATOLOGY; TREMOR; VISUAL HALLUCINATION; VOMITING; WEAKNESS;

HUMANS; MENTAL DISORDERS; METALS, HEAVY; ORGANOPHOSPHATES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTROPIC DRUGS; SELF REPORT; SYMPTOM ASSESSMENT;

EID: 84877926937     PISSN: 0193953X     EISSN: 15583147     Source Type: Journal    
DOI: 10.1016/j.psc.2013.02.001     Document Type: Review

References (31)

1. Han D.Y., Hoelzle J.B., Dennis B.C., et al. A brief review of cognitive assessment in neurotoxicology. Neurol Clin 2011, 29(3):581-590.
2. Caban-Holt A., Mattingly M., Cooper G., et al. Neurodegenerative memory disorders: a potential role of environmental toxins. Neurol Clin 2005, 23(2):485-521.
3. Wright P., Seth R. Lithium toxicity, hypomania and leukocytosis with fluoxetine. Ir J Psychol Med 1992, 9(1):59-60.
4. Nagasawa H., Hayashi H., Otani K. Capgras syndrome occurring in lithium toxicity. Clin Neuropharmacol 2012, 35(4):204.
5. Gil-Gouveia R., Goadsby P.J. Neuropsychiatric side-effects of lidocaine: examples from the treatment of headache and a review. Cephalalgia 2009, 29(5):496-508.
6. Carr A., Cooper D.A. Adverse effects of antiretroviral therapy. Lancet 2000, 356(9239):1423-1430.
7. Schmitt F.A., Bigley J.W., McKinnis R., et al. Neuropsychological outcome of zidovudine (AZT) Treatment of patients with AIDS and AIDS-related complex. N Engl J Med 1988, 319(24):1573-1578.
8. Gouzoulis-Mayfrank E., Daumann J. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?. Addiction 2006, 101(3):348-361.
9. Morgan M.J. Recreational use of " Ecstasy" (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 1998, 19(4):252-264.
10. Daumann J., Pelz S., Becker S., et al. Psychological profile of abstinent recreational Ecstasy (MDMA) users and significance of concomitant cannabis use. Hum Psychopharmacol 2001, 16(8):627-633.
11. MacInnes N., Handley S.L., Harding G.F. Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms. J Psychopharmacol 2001, 15(3):181-186.
12. McCardle K., Luebbers S., Carter J.D., et al. Chronic MDMA (ecstasy) use, cognition and mood. Psychopharmacology 2004, 173(3-4):434-439.
13. Medina K.L., Shear P.K. Anxiety, depression, and behavioral symptoms of executive dysfunction in ecstasy users: contributions of polydrug use. Drug Alcohol Depend 2007, 87(2-3):303-311.
14. Rhodes D., Spiro A., Aro A., et al. Relationship to bone and blood lead levels to psychiatric symptoms: the normative aging study. J Occup Environ Med 2003, 45(11):1144-1151.
15. Bouchard M., Mergler D., Baldwin M., et al. Neuropsychiatric symptoms and past manganese exposure in a ferro-alloy plant. Neurotoxicology 2007, 28(2):290-297.
16. Naby S.A., Hassanein M. Neuropsychiatric manifestations of chronic manganese poisoning. J Neurol Neurosurg Psychiatr 1965, 28:282.
17. Racette B.A., Perlmutter J.S. Welding-related parkinsonism: clinical features, treatment, and pathophysiology. Neurology 2001, 57(9):1739. [reply].
18. Huang C.C., Chu N.S., Lu C.S., et al. Chronic manganese intoxication. Arch Neurol 1989, 46(10):1104-1106.
19. Barceloux D.G. Manganese. J Toxicol Clin Toxicol 1999, 37(2):293-307.
20. Gallo M.A., Lawryk N.J. Organic phosphorus pesticides 1991, Academic Press, San Diego (CA).
21. Mearns J., Dunn J., Leeshaley P.R. Psychological effects of organophosphate pesticides - a review and call for research by psychologists. J Clin Psychol 1994, 50(2):286-294.
22. Colosio C., Tiramani M., Maroni M. Neurobehavioral effects of pesticides: state of the art. Neurotoxicology 2003, 24(4-5):577-591.
23. Ross S.J., Brewin C.R., Curran H.V., et al. Neuropsychological and psychiatric functioning in sheep farmers exposed to low levels of organophosphate pesticides. Neurotoxicol Teratol 2010, 32(4):452-459.
24. Morrow L.A., Stein L., Bagovich G.R., et al. Neuropsychological assessment, depression, and past exposure to organic solvents. Appl Neuropsychol 2001, 8:65-73.
25. Derogatis L.R., Melisaratos N. The brief symptom inventory - an introductory report. Psychol Med 1983, 13(3):595-605.
26. Derogatis L.R. SCL-90-R, administration, scoring, and procedures. Manual for the (revised) version 1977, John Hopkins University School of Medicine, Baltimore (MD).
27. Butcher J.N., Dahlstrom W.G., Graham J.R., et al. Manual for the restandardized Minnesota Multiphasic Personality Inventory: MMPI-2. An administrative and interpretive guideline 1989, University of Minnesota Press, Minneapolis (MN).
28. Heuchert J.P., McNair D.M. Profile of mood states 2004, Multi-Health Systems, Toronto. 2nd edition.
29. Beck A.T., Steer R.A., Brown G. Beck depression inventory-II manual 1996, The Psychological Corporation, San Antonio (TX).
30. Beck A.T., Steer R.A. Beck anxiety inventory manual 1987, The Psychological Corporation, San Antonio (TX).
31. First M.B., Spitzer R.L., Gibbon M., et al. Structured clinical interview for DSM-IV axis I disorders (SCID-I), clinical version, user's guide 1997, American Psychiatric Publishing, Arlington, VA.